FBR Capital

Analysts at FBR Capital upgraded Yahoo! (NASDAQ: YHOO) from Market Perform to Outperform. The price target for Yahoo! has been raised from $40 to $50. Yahoo! shares have surged 21.39% over the past 52 weeks, while the S&P 500 index has gained 10.64% in the same period. Yahoo's shares surged 3...

Netflix Inc. (NASDAQ: NFLX) shares crashed Thursday on disappointing third-quarter subscriber growth and news that Time Warner Inc.'s (NYSE: TWX) HBO Go unit will compete in the streaming movie sector. "It's an eye-popping reaction to a modest miss" in subscriber growth, FBR's Barton Crockett said...

Analysts at FBR Capital upgraded Bank of America (NYSE: BAC) from Market Perform to Outperform. The price target for Bank of America has been raised from $18.00 to $20.00. Bank of America shares have gained 7.50% over the past 52 weeks, while the S&P 500 index has surged 7.46% in the same...

Shares of Advanced Micro Devices, Inc. (NYSE: AMD) experienced a sharp decline in share price afterhours Monday on the heels of no apparent news. Shares closed Monday's session at $2.74, up 0.74 percent, then sold off roughly 18 percent to an after-hours low of $2.22. In Tuesday's...

Analysts at FBR Capital upgraded Helmerich & Payne (NYSE: HP) from Market Perform to Outperform. The price target for Helmerich & Payne has been raised from $120 to $108. Helmerich & Payne shares have gained 5.09% over the past 52 weeks, while the S&P 500 index has surged 9.62% in...

Shares of semiconductor companies are on watch Friday following FBR Capital's removal of ON Semiconductor Corp (NASDAQ: ONNN) from its “Top Picks” list. FBR stated that it is assuming a "more defensive" tone in its semiconductor coverage following Microchip Technology...

Shares of Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) are trending higher Wednesday following positive comments from FBR Capital. Andrew Berens maintained an Outperform rating and $12 price target. Berens noted that Achillion’s NS5a inhibitor is considered to be the best in class....

Analysts at FBR Capital upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Market Perform to Outperform. The target price for AMAG Pharmaceuticals has been raised from $21 to $36. AMAG Pharmaceuticals shares have surged 36.08% over the past 52 weeks, while the S&P 500 index has gained 16.68%...

Analysts at FBR Capital downgraded Actuant (NYSE: ATU) from Outperform to Market Perform. The target price for Actuant has been lowered from $40 to $35. Actuant shares have dropped 17.23% over the past 52 weeks, while the S&P 500 index has gained 15.74% in the same period. Actuant's shares...

In a note released September 16, FBR Capital analyst Jake Fuller explained that although it may not be time to step in just yet, Macau valuations are "starting to look interesting." Fuller suggests waiting until a "bottom" is more visible. He commented, "With...

Analysts at FBR Capital downgraded FMC Technologies (NYSE: FTI) from Outperform to Market Perform. The target price for FMC Technologies has been lowered from $68 to $58. FMC Technologies shares have gained 1.71% over the past 52 weeks, while the S&P 500 index has jumped 16.88% in the same...

Analysts at FBR Capital upgraded Atlas Air Worldwide Holdings (NASDAQ: AAWW) from Market Perform to Outperform. The target price for Atlas Air Worldwide has been raised from $35 to $40. Atlas Air Worldwide shares have dropped 29.94% over the past 52 weeks, while the S&P 500 index has surged...

Analysts at FBR Capital upgraded The Hartford Financial Services Group (NYSE: HIG) from Market Perform to Outperform. The target price for Hartford Financial Services has been raised from $37 to $44. Hartford shares have gained 14.89% over the past 52 weeks, while the S&P 500 index has surged...